glp-1 express delivery Understanding GLP-1s and trans GLP-1 Receptor Agonists | New

Subcutaneous delivery supports controlled systemic exposure and predictable GH pulse activation in research protocols

We also recognize the Kailera team for presenting the first ribupatide injection data generated outside of China, marking a meaningful step in establishing its role in the global obesity treatment landscape. It is exciting to see clinical results for both ribupatide injection and ribupatide oral at ADA this year highlighting the potential of ribupatide to deliver differentiated options for people living with obesity and overweight

Balancing the benefits and harms Blood glucose monitoring for hospitalized individuals should be individualized according to their condition and specific medical needs

An intratumor heterogeneityrelated signature for predicting prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma